Nov 1 (Reuters) - Bionomics Ltd BNO.AX :
* RECEIVES FDA CLEARANCE OF IND FOR EVALUATION OF BNC210 IN A PHASE 2 SOCIAL ANXIETY DISORDER PREVAIL STUDY
Source text for Eikon: ID:nASX50fDqk Further company coverage: BNO.AX
((Reuters.Briefs@thomsonreuters.com;))